IPWIRE.COM

ipprospective.com

IP Finance Gains Momentum; Needs Standards | IP P®OSPE©TIVE

http://www.ipprospective.com/investment-intelligence/ip-finance-gains-momentum-needs-standards

IP P OSPE TIVE. IP Finance Gains Momentum; Needs Standards. In the U.S., recent legislation and policy changes have helped to facilitate the use of intangible assets to secure credit. The American Recovery and Reinvestment Act of 2009 (ARRA) provides for $255 million in funding to the U.S. Small Business Administration (SBA) for new deferred loans to be. IP finance is also without critical standards, and it lies at the intersection of two bodies of law, commercial law and IP law, which do not always move...

patentfinds.com

Patent FindS: Deal: Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate

http://www.patentfinds.com/2012/05/deal-merck-and-endocyte-enter-exclusive.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Tuesday, May 8, 2012. Deal: Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate. Merck and Endocyte Inc. announced on April 16, 2012 that they have entered into an agreement potentially worth almost $1B. The deal will develop and commercialize Endocyte's investigational therapeutic candidate vintafolide (EC145). Vintafolide is currently bein...Endocyte ...

patentfinds.com

Patent FindS: Amgen Co-Founder, George Rathmann dies

http://www.patentfinds.com/2012/04/amgen-co-founder-george-rathmann-dies.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Tuesday, April 24, 2012. Amgen Co-Founder, George Rathmann dies. I was a graduate student rotating through Winston Salser's lab at UCLA when Amgen was founded. I saw many of my friends leave the university for this exciting adventure. The Los Angeles Times. Is reporting that George Rathmann, the company's first CEO, died Sunday in Palo Alto. Với dịch vụ ship hàng từ mỹ. Amazon là gì, ebay là gì? Sẽ giúp đẹp da ...

patentfinds.com

Patent FindS: Pending Legislation- "Biosimilar" Products and Market Exclusivity

http://www.patentfinds.com/2009/11/pending-legislation-biosimilar-products.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Tuesday, November 3, 2009. Pending Legislation- "Biosimilar" Products and Market Exclusivity. In both the Senate and the House approved bills that would authorize. The FDA to create an approval pathway for follow-on biologic,. Or "biosimilar," products that would guarantee manufacturers. 12 years of market exclusivity for a new biologic agent before. Any biosimilar product could be approved, even in the absence.

patentfinds.com

Patent FindS: GEN News Story - Difficulty in Patenting Improved Antibodies

http://www.patentfinds.com/2011/07/gen-news-story-difficulty-in-patenting.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Monday, July 11, 2011. GEN News Story - Difficulty in Patenting Improved Antibodies. Centocor Ortho Biotech, Inc. v. Abbott Laboratories. Difficulty in Patenting Improved Antibodies. As always, we encourage you to share your thoughts. Best to all,. Subscribe to: Post Comments (Atom). The CryoPen Cryosurgical System. Is an advanced, state of the art cryosurgery medical device for use in primary care and in women...

patentfinds.com

Patent FindS: "Like" Patent FindS on Facebook!

http://www.patentfinds.com/2012/04/like-patent-finds-on-facebook.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Wednesday, April 4, 2012. Like" Patent FindS on Facebook! Like" Patent FindS on Facebook. And follow us on Twitter. Become a fan to get important updates and helpful tips. Subscribe to: Post Comments (Atom). The CryoPen Cryosurgical System. Is available for acquisition. Search This Patent FindS. Personalized Medicine Market 2011. Patent FindS is Global. Follow me on Twitter. Patent FindS Blog Archive. Mexican I...

patentfinds.com

Patent FindS: Amgen expands oncolytic virus program with $1B acquisition of BioVex

http://www.patentfinds.com/2012/05/amgen-expands-oncolytic-virus-program.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Friday, January 28, 2011. Amgen expands oncolytic virus program with $1B acquisition of BioVex. Oncolytic viruses are now recognized as an important new strategy for treating cancerous tumors. In addition to Genelux, BioVex, Jenneres, Oncolytic Biotech and Oncos Therapeutics are working on releasing positive clinical data sets. The value of this technology was confirmed by the. 1B acquisition of BioVax by Amgen.

patentfinds.com

Patent FindS: Deal: Allylix raises $18.2 million to produce specialized flavor and fragrances

http://www.patentfinds.com/2012/03/germanys-basf-venture-capital-has.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Tuesday, March 13, 2012. Deal: Allylix raises $18.2 million to produce specialized flavor and fragrances. Germany’s BASF Venture Capital has invested $13.5 million in a financing round that raised a total of $18.2 million for Allylix. The San Diego-based renewable chemicals startup that uses fermentation technology and genetically engineered yeast to produce specialized flavor and fragrance chemicals. Is an adv...

patentfinds.com

Patent FindS: Issued Patent Renewal Rates by Industry

http://www.patentfinds.com/2012/05/issued-patent-renewal-rates-by-industry.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Wednesday, May 2, 2012. Issued Patent Renewal Rates by Industry. In a recent blog post, Renewal Rates by Tech Centers. The patent law blog, PatentlyO. Comments (or reader opinions) on the blog post cited the low value of issued biotech patents with narrow claims or failure of compounds in clinical testing. Read more. Bạn cần mua hàng mỹ giá rẻ. Chuyển hàng đức về Việt Nam, gửi hàng đi đà nẵng. Patent FindS is a...

patentfinds.com

Patent FindS: Myriad Case Decided

http://www.patentfinds.com/2011/08/myriad-case-decided.html

Strategic information, goods and services for entrepreneurs, inventors and patent strategists. Monday, August 1, 2011. Prometheus v. Mayo. Bilski v. Kappos. This strongly suggests that. Patent holders work with their outside counsel to review pending and granted diagnostic method claims in light of these decisions. Here are a few good summaries:. Ruling Upholds Gene Patent in Cancer Test New York Times. Appeals Court Decides Isolated DNA Patentable, Myriad Analytical Claims Not Genome Web. Patent FindS B...